-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW) Short Interest Update
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW) Short Interest Update
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) saw a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,300 shares, a decline of 13.3% from the July 31st total of 1,500 shares. Based on an average trading volume of 15,800 shares, the days-to-cover ratio is currently 0.1 days.
Intelligent Medicine Acquisition Price Performance
Shares of Intelligent Medicine Acquisition stock remained flat at $0.10 on Wednesday. The company had a trading volume of 10,900 shares, compared to its average volume of 18,363. Intelligent Medicine Acquisition has a 1 year low of $0.03 and a 1 year high of $0.60.
Get Intelligent Medicine Acquisition alerts:Intelligent Medicine Acquisition Company Profile
(Get Rating)
Intelligent Medicine Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.See Also
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDW)
- Crowdstrike Stock Retraces, As Earnings Sober Expectations
- Will The Institutions Buy The Dip In Ambarella Stock?
- PVH Corporation Is On Track For Capital Returns
- Can Pinterest Rally On Support From Big Investor With Conviction?
- Chargepoint Rallies, Despite Weaker Earnings
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
Intelligent Medicine Acquisition Corp. (NASDAQ:IQMDW – Get Rating) saw a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 1,300 shares, a decline of 13.3% from the July 31st total of 1,500 shares. Based on an average trading volume of 15,800 shares, the days-to-cover ratio is currently 0.1 days.
智能医药收购公司(纳斯达克代码：IQMDW-GET Rating)8月份空头股数股价大幅下跌。截至8月15日，空头股数共有1,300股，较7月31日的1,500股下跌13.3%。以15,800股的平均成交量计算，目前天数与回补比率为0.1天。
Intelligent Medicine Acquisition Price Performance
智能医疗采办性价比
Shares of Intelligent Medicine Acquisition stock remained flat at $0.10 on Wednesday. The company had a trading volume of 10,900 shares, compared to its average volume of 18,363. Intelligent Medicine Acquisition has a 1 year low of $0.03 and a 1 year high of $0.60.
周三，智能医药收购股票的股价持平于0.10美元。该公司成交量为10,900股，而其平均成交量为18,363股。智能医药收购的一年低点为0.03美元，一年高位为0.60美元。
Intelligent Medicine Acquisition Company Profile
智能医药收购公司简介
(Get Rating)
(获取评级)
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMDW)
- Crowdstrike Stock Retraces, As Earnings Sober Expectations
- Will The Institutions Buy The Dip In Ambarella Stock?
- PVH Corporation Is On Track For Capital Returns
- Can Pinterest Rally On Support From Big Investor With Conviction?
- Chargepoint Rallies, Despite Weaker Earnings
- 免费获取StockNews.com关于智能医疗收购的研究报告(IQMDW)
- CrowdStrike股价回落，盈利超出预期
- 这些机构会在安巴雷拉入股抄底吗？
- PVH公司有望实现资本回报
- Pinterest能否坚定地获得大投资者的支持？
- ChargePoint上涨，尽管收益疲软
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受《智能医药采购日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对智能医药收购和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧